A Registry Study on the Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients

What this Trial Is About

Researchers are investigating the management of hypertension, a common and serious cardiovascular disease that can lead to stroke, heart attack, and heart failure. This study focuses on the use of 24-hour ambulatory blood pressure monitoring (ABPM) as recommended by European guidelines to improve hypertension diagnosis and treatment. The research aims to gather nationwide data on hypertensive patients in China to assess differences in cardiovascular outcomes based on ABPM control. Participants in this observational study have hypertension and use antihypertensive medications. They undergo 24-hour ABPM with validated devices, and their clinical information, including disease history and recent blood biochemical tests, is collected. The study promotes the clinical use of ambulatory monitoring to better detect various hypertension types and evaluate treatment effects over time. Throughout the study, researchers record major cardiovascular and cerebrovascular events for up to three years from enrollment. They also track clinic and ambulatory blood pressure control rates, as well as the occurrence of white-coat and masked hypertension. Participants provide consent and data while continuing their usual care. The study aims to improve hypertension management and reduce related health risks in the population.

A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"